Inhibition of melanogenesis as a radiation sensitizer for melanoma therapy

International Journal of Cancer

Volumn 123, Issue 6, 2008, Pages 1448-1456

  Brozyna, Anna A ^a   VanMiddlesworth, Lester ^b   Slominski, Andrzej T ^b  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Gamma radiation; Melanin; Melanogenesis; Melanoma; Tyrosinase

Indexed keywords

MONOPHENOL MONOOXYGENASE; PENICILLAMINE; PHENYLTHIOUREA; RADIOSENSITIZING AGENT;

ARTICLE; CANCER CELL CULTURE; CELL ACTIVITY; CELL VIABILITY; CLINICAL TRIAL; COLONY FORMING UNIT; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INHIBITION; GAMMA RADIATION; HUMAN; HUMAN CELL; IONIZING RADIATION; MELANOGENESIS; MELANOMA; MELANOMA CELL; PHENOTYPE; PRIORITY JOURNAL; RADIATION DOSE; RADIATION EXPOSURE; RADIOSENSITIVITY; RADIOSENSITIZATION;

CELL LINE, TUMOR; CELL SURVIVAL; HUMANS; MELANINS; MELANOMA; MELANOMA, AMELANOTIC; PENICILLAMINE; PHENYLTHIOUREA; RADIATION TOLERANCE; RADIATION, IONIZING; RADIATION-SENSITIZING AGENTS;

EID: 49749108996     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.23664     Document Type: Article

References (46)

1. http://www.melanoma.org.
2. Rakel RE, Bope ET. Conn's current therapy 2005. London: W.B. Saunders Company, 2005:939-41.
3. Carlson JA, Ross JS, Slominski A, Linette G, Mysliborski J, Hill J, Mihm M, Jr. Molecular diagnostics in melanoma. J Am Acad Dermatol 2005;52:743-75; quiz 75-8.
4. Cascinelli N, Heerlyn M, Schneeberger A, Kuweit C, Slominski A, Armstrong C, Belli F, Lukiewcz S, Maurer D, Ansel J, Stingl G, Saida T. What is the most promising strategy for the treatment of metastasizing melanoma? Exp Dermatol 2000;9:439-51.
5. Fenig E, Eidelevich E, Njuguna E, Katz A, Gutman H, Sulkes A, Schechter J. Role of radiation therapy in the management of cutaneous malignant melanoma. Am J Clin Oncol 1999;22:184-6.
6. Jenrette JM. Malignant melanoma: the role of radiation therapy revisited. Semin Oncol 1996;23:759-62.
7. Seegenschmiedt MH, Keilholz L, Altendorf-Hofmann A, Urban A, Schell H, Hohenberger W, Sauer R. Palliative radiotherapy for recurrent and metastatic malignant melanoma: prognostic factors for tumor response and long-term outcome: a 20-year experience. Int J Radiat Oncol Biol Phys 1999;44:607-18.
8. Serrone L, Hersey P. The chemoresistance of human malignant melanoma: an update. Melanoma Res 1999;9:51-8.
9. Soengas MS, Lowe SW. Apoptosis and melanoma chemoresistance. Oncogene 2003;22:3138-51.
10. Lukiewicz S. Interference with endogenous radioprotectors as a method of radiosensitization modification of radiosensitivity of biological systemsed. Vienna: International Atomic Energy Agency, 1976:61-76.
11. Slominski A, Tobin DJ, Shibahara S, Wortsman J. Melanin pigmentation in mammalian skin and its hormonal regulation. Physiol Rev 2004;84:1155-228.
12. Kollias N, Sayre RM, Zeise L, Chedekel MR. Photoprotection by melanin. J Photochem Photobiol B 1991;9:135-60.
13. Meyskens FL, Jr, Farmer P, Fruehauf JP. Redox regulation in human melanocytes and melanoma. Pigment Cell Res 2001;14:148-54.
14. Pawelek JM, Chakraborty AK, Osber MP, Orlow SJ, Min KK, Rosenzweig KE, Bolognia JL. Molecular cascades in UV-induced melanogenesis: a central role for melanotropins? Pigment Cell Res 1992;5:348-56.
15. Smit NP, Vink AA, Kolb RM, Steenwinkel MJ, van den Berg PT, van Nieuwpoort F, Roza L, Pavel S. Melanin offers protection against induction of cyclobutane pyrimidine dimers and 6-4 photoproducts by UVB in cultured human melanocytes. Photochem Photobiol 2001;74:424-30.
16. Wood JM, Jimbow K, Boissy RE, Slominski A, Plonka PM, Slawinski J, Wortsman J, Tosk J. What's the use of generating melanin? Exp Dermatol 1999;8:153-64.
17. Schwabe K, Lassmann G, Damerau W, Naundorf H. Protection of melanoma cells against superoxide radicals by melanins. J Cancer Res Clin Oncol 1989;115:597-600.
18. Ripley S. Is nuclear medicine cost-effective? Dimens Health Serv 1991;68:21-3.
19. Slominski A, Paus R, Mihm MC. Inhibition of melanogenesis as an adjuvant strategy in the treatment of melanotic melanomas: selective review and hypothesis. Anticancer Res 1998;18:3709-15.
20. Slominski A, Wortsman J, Carlson AJ, Matsuoka LY, Balch CM, Mihm MC. Malignant melanoma. Arch Pathol Lab Med 2001;125:1295-306.
21. Meyskens FL, Jr, Farmer PJ, Anton-Culver H. Etiologic pathogenesis of melanoma: a unifying hypothesis for the missing attributable risk. Clin Cancer Res 2004;10:2581-3.
22. Chalmers AH, Lavin M, Atisoontornkul S, Mansbridge J, Kidson C. Resistance of human melanoma cells to ultraviolet radiation. Cancer Res 1976;36:1930-4.
23. Cobb JP. Effect of in vitro X irradiation on pigmented and pale slices of Cloudman S91 mouse melanoma as measured by subsequent proliferation in vivo. J Natl Cancer Inst 1956;17:657-66.
24. Hopwood LE, Swartz HM, Pajak S. Effect of melanin on radiation response of CHO cells. Int J Radiat Biol Relat Stud Phys Chem Med 1985;47:531-7.
25. Pajak S, Subczynski W, Panz T, Lukiewicz S. Rate of oxygen consumption of hamster melanoma cells as a factor influencing their radioresistance. Folia Histochem Cytochem (Krakow) 1980;18:33-9.
26. Mileo AM, Mattei E, Fanuele M, Delpino A, Ferrini U. Differential radiosensitivity in cultured B-16 melanoma cells following interrupted melanogenesis induced by glucosamine. Pigment Cell Res 1989;2:167-70.
27. Urbanska K, Romanowska-Dixon B, Elas M, Pajak S, Paziewski E, Bryk J, Kukielczak B, Slominski A, Zygulska-Mach H, Lukiewicz S. Experimental ruthenium plaque therapy of amelanotic and melanotic melanomas in the hamster eye. Melanoma Res 2000;10:26-35.
28. Kinnaert E, Morandini R, Simon S, Hill HZ, Ghanem G, Van Houtte P. The degree of pigmentation modulates the radiosensitivity of human melanoma cells. Radiat Res 2000;154:497-502.
29. Lukiewicz S. Electron spin resonance studies on the detectability of radiation damage and radiosensitization of neoplastic cells. Improvement in radiotherapy of cancer using modifier of radiosensitivity of cells. Julich: International Atomic Energy Agency, 1981.
30. Slominski A, Paus R, Schadendorf D. Melanocytes as "sensory" and regulatory cells in the epidermis. J Theor Biol 1993;164:103-20.
31. Slominski A, Ermak G, Wortsman J. Modification of melanogenesis in cultured human melanoma cells. In Vitro Cell Dev Biol Anim 1999;35:564-5.
32. Moellmann G, Slominski A, Kuklinska E, Lerner AB. Regulation of melanogenesis in melanocytes. Pigment Cell Res 1988;(Suppl 1):79-87.
33. Slominski A, Zbytek B, Pisarchik A, Slominski RM, Zmijewski MA, Wortsman J. CRH functions as a growth factor/cytokine in the skin. J Cell Physiol 2006;206:780-91.
34. Vaupel P, Briest S, Hockel M. Hypoxia in breast cancer: pathogenesis, characterization and biological/therapeutic implications. Wien Med Wochenschr 2002;152:334-42.
35. Vaupel P, Mayer A. Hypoxia in cancer: significance and impact on clinical outcome. Cancer Metastasis Rev 2007;26:225-39.
36. Scislowski PW, Slominski A, Bomirski A. Biochemical characterization of three hamster melanoma variants. II. Glycolysis and oxygen consumption. Int J Biochem 1984;16:327-31.
37. Watts KP, Fairchild RG, Slatkin DN, Greenberg D, Packer S, Atkins HL, Hannon SJ. Melanin content of hamster tissues, human tissues, and various melanomas. Cancer Res 1981;41:467-72.
38. Cieszka K, Gurbiel RJ. Radiosensitivity of hamster melanoma to fast neutrons (in Polish). Sci Ann Jagiellonian Univ 1982;9:319-24.
39. Hill HZ, Cathcart KN, Bargellini J, Trizna Z, Hill GJ, Schallreuter KU, Wood JM. Does melanin affect the low LET radiation response of Cloudman S91 mouse melanoma cell lines? Pigment Cell Res 1991;4:80-6.
40. Barranco SC, Romsdahl MM, Humphrey RM. The radiation response of human malignant melanoma cells grown in vitro. Cancer Res 1971;31:830-3.
41. Mosse I, Kostrova L, Subbot S, Maksimenya I, Molophei V. Melanin decreases clastogenic effects of ionizing radiation in human and mouse somatic cells and modifies the radioadaptive response. Radiat Environ Biophys 2000;39:47-52.
42. Kaur J, Hill HZ. Transfection of nonmelanocytic cells with tyrosinase gene constructs for survival studies. Environ Mol Mutagen 2001;38:216-22.
43. Grossi GF, Durante M, Gialanella G, Pugliese M, Mosse I. Effects of melanin on high- and low- linear energy transfer (LET) radiation response of human epithelial cells. Radiat Environ Biophys 1998;37:63-7.
44. Mueller AJ, Talies S, Schaller UC, Horstmann G, Wowra B, Kampik A. Stereotactic radiosurgery of large uveal melanomas with the gamma-knife. Ophthalmology 2000;107:1381-7; discussion 7-8.
45. Schmid-Wendtner MH, Brunner B, Konz B, Kaudewitz P, Wendtner CM, Peter RU, Plewig G, Volkenandt M. Fractionated radiotherapy of lentigo maligna and lentigo maligna melanoma in 64 patients. J Am Acad Dermatol 2000;43:477-82.
46. Bomirski A, Slominski A, Bigda J. The natural history of a family of transplantable melanomas in hamsters. Cancer Metastasis Rev 1988;7:95-118.